Bard Associates Inc. Has $3.67 Million Holdings in Quaker Chemical Corp (KWR)

Share on StockTwits

Bard Associates Inc. decreased its position in Quaker Chemical Corp (NYSE:KWR) by 3.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,690 shares of the specialty chemicals company’s stock after selling 910 shares during the quarter. Quaker Chemical accounts for approximately 1.7% of Bard Associates Inc.’s portfolio, making the stock its 8th largest position. Bard Associates Inc. owned about 0.18% of Quaker Chemical worth $3,669,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in KWR. Millennium Management LLC purchased a new stake in shares of Quaker Chemical during the fourth quarter worth $320,000. Wells Fargo & Company MN increased its position in shares of Quaker Chemical by 0.4% during the first quarter. Wells Fargo & Company MN now owns 207,693 shares of the specialty chemicals company’s stock worth $30,766,000 after acquiring an additional 929 shares during the period. Comerica Bank increased its position in shares of Quaker Chemical by 2.9% during the first quarter. Comerica Bank now owns 14,270 shares of the specialty chemicals company’s stock worth $2,195,000 after acquiring an additional 399 shares during the period. SG Americas Securities LLC increased its position in shares of Quaker Chemical by 38.8% during the first quarter. SG Americas Securities LLC now owns 2,064 shares of the specialty chemicals company’s stock worth $306,000 after acquiring an additional 577 shares during the period. Finally, Prudential Financial Inc. increased its position in shares of Quaker Chemical by 2.2% during the first quarter. Prudential Financial Inc. now owns 23,282 shares of the specialty chemicals company’s stock worth $3,449,000 after acquiring an additional 500 shares during the period. 98.17% of the stock is currently owned by institutional investors.

Shares of KWR stock opened at $189.87 on Friday. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.78 and a quick ratio of 2.15. The firm has a market cap of $2.52 billion, a P/E ratio of 37.90, a PEG ratio of 2.90 and a beta of 1.35. Quaker Chemical Corp has a 12 month low of $137.95 and a 12 month high of $192.65.

Quaker Chemical (NYSE:KWR) last issued its earnings results on Monday, July 30th. The specialty chemicals company reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.43 by $0.13. The firm had revenue of $221.96 million during the quarter, compared to the consensus estimate of $214.72 million. Quaker Chemical had a net margin of 3.89% and a return on equity of 17.27%. The company’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.24 earnings per share. sell-side analysts anticipate that Quaker Chemical Corp will post 5.93 earnings per share for the current year.

A number of research firms have recently weighed in on KWR. Zacks Investment Research raised Quaker Chemical from a “hold” rating to a “buy” rating and set a $211.00 price objective on the stock in a research report on Tuesday, September 11th. B. Riley set a $170.00 price objective on Quaker Chemical and gave the stock a “hold” rating in a research report on Tuesday, July 31st. Finally, Janney Montgomery Scott started coverage on shares of Quaker Chemical in a research note on Friday, July 13th. They set a “neutral” rating and a $170.00 target price for the company. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $176.20.

In related news, VP D Jeffry Benoliel sold 2,000 shares of the business’s stock in a transaction on Wednesday, August 8th. The shares were sold at an average price of $167.93, for a total transaction of $335,860.00. Following the completion of the transaction, the vice president now owns 11,531 shares in the company, valued at $1,936,400.83. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, VP Joseph A. Berquist sold 1,000 shares of the business’s stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $190.64, for a total transaction of $190,640.00. Following the transaction, the vice president now owns 10,411 shares of the company’s stock, valued at approximately $1,984,753.04. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,520 shares of company stock valued at $1,486,414. Insiders own 3.20% of the company’s stock.

Quaker Chemical Profile

Quaker Chemical Corporation develops, produces, and markets various formulated chemical specialty products for a range of heavy industrial and manufacturing applications in North America, Europe, the Middle East, Africa, the Asia/Pacific, and South America. Its products include rolling lubricants used by manufacturers of steel in the hot and cold rolling of steel, and aluminum in the hot rolling of aluminum; machining and grinding compounds for use in cutting, shaping, and grinding metal parts; hydraulic fluids for steel, metalworking, and other customers to operate hydraulic equipment; corrosion preventives to protect metals during manufacture, storage, and shipment; and specialty greases used in automotive and aerospace production processes, steel manufacturing, and various other applications.

Featured Article: Technical Analysis of Stocks and What It Means

Institutional Ownership by Quarter for Quaker Chemical (NYSE:KWR)

Receive News & Ratings for Quaker Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quaker Chemical and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.